![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hanton Gilles Tilbury Lorraine
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.5, Iss.2, 2006-03, pp. : 329-333
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Danjou P.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cardiac safety of sunitinib questioned
Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Preclinical Cardiac Safety Assessment of Drugs
Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin: efficacy and safety in reducing cardiac events
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. :